Promentis Pharmaceuticals to Present at the 11th Anniversary CNS Summit
MILWAUKEE, Oct. 31, 2020 /PRNewswire/ — Promentis Pharmaceuticals, Inc., a privately held biopharmaceutical company developing innovative therapies for neuropsychiatric disorders, announced that Dr. Chad E. Beyer, Senior Vice President of R&D, will present psychometric results from…
Comments Off on Promentis Pharmaceuticals to Present at the 11th Anniversary CNS Summit